$11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc

Sep 30, 2026

Today's landmark defense contract launches the FDA-approved SPARC-TMS trial while NRx simultaneously advances its preservative-free ketamine program, HOPE Therapeutics and an expanding CNS pipeline

MIAMI - Sept. 30, 2026 - PRLog -- NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP enters the final days of September with one of its most significant developments of 2026: its NRx Defense Systems subsidiary has been awarded an initial $11,177,757.27 prime contract from the Defense Advanced Research Projects Agency (DARPA) to evaluate robotic magnetic stimulation in combination with NRX-101 for treatment-resistant depression.

Even more importantly for investors, the underlying SPARC-TMS clinical trial has received FDA approval and will now begin enrolling patients. The program is designed to test whether an entire course of TMS can potentially be delivered in a single day when combined with NRX-101 and robotic neuronavigated TMS.

This is particularly notable because NRx had previously disclosed that it had been selected by DARPA for the program with anticipated non-dilutive funding exceeding $11.5 million, subject to contracting. Today's announcement represents the actual initial contract award of $11.18 million, providing a significant validation of the program while supporting its clinical development without relying solely on equity financing.

Today's $11.18 Million DARPA Catalyst

The SPARC-TMS program — Synaptic Plasticity Augmented Rapid Circuit Stimulation — is being conducted by NRx Defense Systems in partnership with Harvard Medical School's McLean Hospital, Arizona State University, HOPE Therapeutics, Zeta Surgical Systems and Neurocare of America.

The trial is expected to evaluate a single-day treatment approach combining robotic neuronavigated TMS with NRX-101.

According to today's announcement:
  • $11,177,757.27 initial DARPA prime contract awarded
  • FDA-approved SPARC-TMS trial can now begin enrolling patients
  • Study sites include McLean Hospital, Arizona State University and HOPE Therapeutics
  • Plans are underway to expand the program to leading military hospitals
  • If the clinical results are successfully replicated, the study could potentially serve as an FDA registration study for NRX-101 in combination with TMS.

NRx also highlighted previously published real-world findings showing 91% treatment response and 69% remission at three months following traditional TMS combined with D-cycloserine. Those findings are not evidence that the SPARC-TMS trial will produce the same results; the company will need to establish the efficacy and safety of the new protocol through the clinical trial.

The FDA Ketamine Story Is Also Moving Forward

While today's DARPA announcement grabs the spotlight, NRx has another major potential catalyst developing.

On September 15, the company announced that the FDA had reclassified the amendment concerning the vial for preservative-free ketamine from a Major Amendment to a Minor Amendment and revised the GDUFA goal date to November 10, 2026.

That follows the August FDA first-cycle review of NRx's ANDA, when the agency identified no major deficiencies involving the ketamine product, ingredients, proposed labeling, CMC or other product-related matters. The remaining issue involved certification concerning the luer-lock vial.

NRx reported that the same vial system was already being used in three FDA-approved ANDA products, with approximately 11.9 million units shipped over the preceding 12 months without complaints, returns, adverse events or recalls. The company also stated that no new clinical, safety or efficacy data were required for ANDA approval.

The November 10 GDUFA date therefore gives investors a clearly defined regulatory milestone to watch.

Commercial Preparation Is Already Underway

NRx isn't waiting until a potential approval to prepare its commercial infrastructure.

The company began commercial-scale manufacturing of preservative-free ketamine in May, with manufacturing designed to scale as demand develops. By August, NRx reported that it was building an initial launch inventory of approximately 5 million doses, while targeting manufacturing capacity of approximately 1 million doses per month after launch.

NRx also appointed Glenn Tyson as its first Chief Commercial Officer and began building a commercial launch organization.

That combination — regulatory progress, manufacturing preparation and commercial personnel — gives the ketamine program a considerably different profile than a purely early-stage research program.

HOPE Therapeutics and Robotic TMS Add Another Layer

NRXP's story has also expanded beyond its pharmaceutical pipeline.

In June, HOPE Therapeutics treated its first patients using Zeta Surgical's FDA-cleared Zeta TMS Navigation System at clinics in West Palm Beach and Sarasota, Florida. The system uses AI-driven image guidance and computer vision to track TMS positioning with submillimetric accuracy.

Then, on September 11, NRx announced that HOPE's clinical team had begun training for deployment of Zeta Surgical's newly FDA-cleared TMS Robotic System in Florida. The robotic system builds on the navigation platform and is designed to position and continually adjust the TMS coil with submillimeter precision.

That technology is now directly connected to today's DARPA-funded SPARC-TMS program.

NRX-101 Continues to Build Strategic Optionality

NRX-101 received FDA clearance to proceed with a Phase 2/3 trial combining the therapy with robotic-enabled TMS back in May. The planned program includes civilian and military treatment facilities and was designed around the potential for rapid treatment of treatment-resistant depression.

In June, FDA also granted an Expanded Access Protocol for NRX-101 in combination with accelerated TMS, providing another avenue for physicians to access the investigational therapy for appropriate patients who cannot participate in the pivotal trial.

A Broader CNS Pipeline Is Emerging

NRXP's recent developments increasingly show a company building multiple potential value drivers rather than relying on one program.

In September, NRx's GeNeuro subsidiary announced European patent protection for GNK-301, a monoclonal antibody candidate targeting HERV-K envelope protein in ALS. GeNeuro has initiated GMP manufacturing and anticipates Phase 1 testing in ALS in the second half of 2027, subject to development and regulatory progress.

NRx also strengthened its balance sheet earlier this year by closing a $22.3 million public offering, with proceeds intended for working capital and general corporate purposes.

Why Investors Are Watching $NRXP Closely

The latest developments create several distinct catalysts:
  • $11.18 million DARPA prime contract awarded today
  • FDA-approved SPARC-TMS trial moving into patient enrollment
  • November 10, 2026 FDA GDUFA goal date for the preservative-free ketamine ANDA
  • 5 million-dose Commercial Inventories being built
  • HOPE/Zeta robotic TMS deployment progressing in Florida
  • NRX-101 advancing through an FDA-cleared clinical program
  • European patent protection and future Phase 1 potential for GNK-301
  • $22.3 million public financing completed earlier this year

Taken together, these developments give NRx Pharmaceuticals several independent milestones to follow into the fourth quarter and beyond.

For investors, the most important distinction is that some catalysts are now achieved while others remain prospective. Today's $11.18 million DARPA contract and FDA clearance of SPARC-TMS are concrete milestones. Potential FDA approval of preservative-free ketamine, clinical outcomes from SPARC-TMS, future NRX-101 approval and commercialization, and GNK-301 development remain subject to regulatory, clinical and commercial risks.

Still, September 30, 2026 represents a significant new chapter for NRx Pharmaceuticals. The company now has an actual DARPA-funded clinical program, a defined FDA goal date for its preservative-free ketamine ANDA, an expanding robotic-TMS platform through HOPE, and a growing CNS pipeline.

For $NRXP shareholders and investors watching the company closely, the fourth quarter could therefore be an important period as these programs move from development and preparation toward increasingly tangible clinical, regulatory and commercial milestones.

For more information on $NRXP visit: https://www.nrxpharma.com/ and https://compasslivemedia.com/case-study/nrx-pharmaceuticals/

Media Contact
Company Name: NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP)
Contact Person: Brian Korb, Managing Partner, astr partners
Email: [email protected]
Phone: (917) 653-5122
Country: United States

DISCLAIMER: https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website

Contact
CorporateAds
***@gmail.com

Photos: (Click photo to enlarge)




Source: CorporateAds

Read Full Story - $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc | More news from this source

Press release distribution by PRLog
MORE NEWS
KCCI, audit authority collaborate to resume construction of 4,000 public housing units
Oct 7, 2026
KCCI, audit authority collaborate to resume construction of 4,000 public housing units

The audit authority has cleared a key hurdle for six stalled public housing projects totaling nearly 4,000 units after the Korea Chamber of Commerce and Industry (KCCI) sought a preliminary consultation on behalf of builders struggling with soaring construction costs. The KCCI said on Tuesday that the Board of Audit and Inspection (BAI) determined that project costs for the six sites, covering 3,936 housing units, can be recalculated to reflect current market conditions. The case marks the KCCI’s first use of the consultation program since it was opened to private organizations in May. “Companies have faced difficulties for a long time, but this was not an issue they could easily make a decision on,” Lee Jong-myung, head of the KCCI's industry innovation division, said. “The BAI's decision to open its doors to the private sector has added another channel for resolving corporate difficulties, and its first result will benefit the public through housing supply.” The six projects are part of a public-private housing program, with public agencies providing the land while private bu

Private sector's role increased in 5th Nuri launch
Oct 7, 2026
Private sector's role increased in 5th Nuri launch

Private companies played a significantly greater role in the successful fifth launch of Korea’s Nuri rocket on Wednesday, signaling that the country’s efforts to keep pace with the global shift toward a private sector-led “New Space” era are gaining momentum. The Nuri rocket completed its fifth launch and 20-minute-long flight successfully after lifting off at the Naro Space Center in Goheung, Jeonnam-Gwangju Special Metropolitan City, at 12:25 p.m. The most notable change in the latest launch was not the rocket itself, but the growing presence of private-sector personnel at the launch site. Hanwha Aerospace has overseen the manufacturing of the Nuri rocket as its system integrator since the fourth launch on Nov. 27 last year, but this time, its role expanded to the consoles at the launch control center. Hanwha Aerospace deployed 42 staffers for the fifth launch. They participated in operations at 20 of the 22 consoles responsible for launch vehicle systems, and at 18 of them, Hanwha employees directly operated the controls instead of specialists from the Korea Aerospace Researc

[EXPLAINER] How AI emerged as new threat in Korea's bank hacking crisis
Oct 7, 2026
[EXPLAINER] How AI emerged as new threat in Korea's bank hacking crisis

Hackers once had to manually test security defenses, identify vulnerabilities and work out how to exploit them. Now, artificial intelligence (AI) can do much of that work, requiring little human input. That possibility is at the center of Korea's latest security crisis in the financial sector, as investigators have found traces of an AI-powered autonomous penetration-testing tool in a series of recent cyberattacks on the country's major banks. Since last week, Shinhan Bank, KB Kookmin Bank, Hana Bank, Yegaram Savings Bank and BNK Busan Bank have all reported data breaches, while Woori Bank and NH NongHyup Bank have detected signs of hacking attempts, though no data leaks were confirmed. Shinhan Bank reported that about 25,000 customers were affected, with personal information including names, phone numbers, annual income and loan limits exposed. KB Kookmin reported 119 affected customers, while Hana Bank said personal information belonging to 89 customers was exposed. The hacking spree has drawn particular concern after investigators reportedly found traces of an AI-powered tool known as

SK Energy, HD Hyundai Oilbank face fines over alleged fuel price fixing
Oct 7, 2026
SK Energy, HD Hyundai Oilbank face fines over alleged fuel price fixing

SK Energy and HD Hyundai Oilbank may face sanctions from the Fair Trade Commission (FTC) over allegations that they colluded on gasoline, diesel and kerosene prices, with combined fines potentially reaching 4.63 trillion won ($3.45 billion). The antitrust regulator said Wednesday that it sent a review report to the two companies, formally launching deliberations over the alleged price-fixing case. The FTC said the alleged collusion lasted from February 2022, shortly before Russia's invasion of Ukraine, through March this year, shortly after the outbreak of the war in Iran. The case covers petroleum products that are essential to household and economic activity. Korea's oil refining industry is highly concentrated, with SK Energy, HD Hyundai Oilbank, GS Caltex and S-Oil accounting for about 98 percent of the domestic market. According to the FTC, SK Energy and HD Hyundai Oilbank exchanged information on the prices of gasoline, diesel and kerosene, including provisional prices, final prices and sales policies. The regulator also determined that the two companies colluded on prices followin

Beef tallow remains hurdle to Charrr's global expansion
Oct 7, 2026
Beef tallow remains hurdle to Charrr's global expansion

Countries’ regulations on imported foods containing beef tallow pose a hurdle for Samyang Foods as the Korean instant noodle giant seeks to expand exports of its latest black bean sauce instant noodles, Charrr. The company has established Buldak as a massively popular product around the globe without using beef tallow, selling 10 billion units and generating cumulative sales of 7 trillion won ($5.2 billion) as of June. Unlike the spicy, brothless instant noodle brand, however, Charrr uses beef tallow as a key ingredient to give its sauce a rich, beefy flavor. Charrr is not Samyang’s first instant noodle product using beef tallow. The company launched Samyang 1963 in November last year with the ambitious goal of reviving the “forgotten” taste of its first instant noodle product, Samyang Ramen, which was introduced in 1963 and used beef tallow. Samyang Ramen, introduced by the late company founder Chun Joong-yoon to help feed a population suffering from widespread poverty at the time, remains a cornerstone of the company’s identity. Its use of beef tallow has now become part of

Bank data breach victims step up calls for compensation
Oct 7, 2026
Bank data breach victims step up calls for compensation

A growing number of customers affected by a string of recent personal data breaches at major commercial banks and other financial firms appear to be turning to class action lawsuits in pursuit of compensation, according to industry officials, Wednesday. The banks have pledged to fully compensate customers whose losses, including those from voice phishing scams, are found to have directly resulted from the leaks. But proving that a loss was caused by a specific data breach can be difficult in practice, and the banks have yet to set out clear standards for determining which claims would qualify, prompting some victims to resort to legal action. Seven financial firms have reported information leaks so far, including three of the country’s largest commercial lenders — Shinhan Bank, KB Kookmin Bank and Hana Bank. Shinhan reported the largest breach, affecting around 25,000 people, followed by 119 at KB Kookmin and 89 at Hana Bank. The exposed data includes customers’ names, contact details, resident registration numbers, annual income and loan limits. The combination of personal and fin

[COVER STORY] Nuri rocket successfully completes 5th flight
Oct 7, 2026
[COVER STORY] Nuri rocket successfully completes 5th flight

Korea’s home-developed Nuri rocket successfully carried out its mission in its fifth launch Wednesday, sequentially deploying 14 out of 15 satellites it carried into their target orbit. The key objective of the fifth launch was to safely deploy the five microsatellite constellations, and the success has demonstrated Korea's increased multi-satellite launch capabilities, taking another step toward privately led commercial launch services. The rocket lifted off from the launchpad at the Naro Space Center in Goheung, Jeonnam-Gwangju Special Metropolitan City, at 12:25 p.m. and completed its roughly 20-minute flight at around 12:45 p.m. The rocket separated its first stage about two minutes after liftoff, followed by the second stage about four and a half minutes into the flight. At around 12:40 p.m., it reached an altitude of 570 kilometers and completed the sequential deployment of five New-space Earth Observation Satellite Constellation for National Safety (NEONSAT) microsatellites (satellites No. 2 to 6), its primary payload, along with nine of the 10 CubeSats it carried. Initially, th

Nuri rocket deploys 14 satellites, 1 CubeSat fails to release
Oct 7, 2026
Nuri rocket deploys 14 satellites, 1 CubeSat fails to release

The Nuri rocket successfully lifted off on its fifth launch and deployed 14 of the 15 satellites it carried into their target orbit Wednesday. The rocket lifted off from the second launch pad at the Naro Space Center in Goheung, Jeonnam-Gwangju Special Metropolitan City, at 12:25 p.m. and completed its roughly 20-minute flight at around 12:45 p.m. The rocket separated its first stage about two minutes after liftoff, followed by the second stage about four and a half minutes into the flight. At around 12:40 p.m., it reached an altitude of 570 kilometers and completed the sequential deployment of five NEONSAT swarm microsatellites (satellite No. 2 to 6), its primary payload, along with nine of the 10 CubeSats it carried. Initially, the Nuri sent signals indicating that all of the CubeSats had been successfully deployed. However, subsequent checks found that PERSAT02, developed by Quaternion, had failed to separate from the rocket. The flight ended at around 12:45 p.m. after the third stage completed its autopilot sequence. "The Nuri rocket successfully completed its planned fifth launch mis

Southeast Asia’s foodtech winners are the least glamorous ones
Oct 7, 2026
Southeast Asia’s foodtech winners are the least glamorous ones

Southeast Asia’s foodtech story was supposed to be about disruption: lab-grown shrimp on every plate, groceries at your door in 15 minutes, ghost kitchens replacing the corner restaurant. The reality has been humbler, and arguably more interesting. The 2022 correction thinned the herd, the eFishery scandal and TaniHub’s collapse left scars, and many of the […] The post Southeast Asia’s foodtech winners are the least glamorous ones appeared first on e27.

When the carer has dementia too: Japan turns to physical AI to rescue eldercare
Oct 7, 2026
When the carer has dementia too: Japan turns to physical AI to rescue eldercare

Some Japanese words resist translation. Take rōrō kaigo (老老介護). The character rō means “elderly”, and repeating it describes an elderly person caring for another elderly person, such as an 80-year-old husband looking after his equally frail wife on his own. That is the reality the word captures. Then there is the darker ninnin kaigo (認認介護). […] The post When the carer has dementia too: Japan turns to physical AI to rescue eldercare appeared first on e27.

Southeast Asian tech leaders are learning to trust AI agents, but not with production
Oct 7, 2026
Southeast Asian tech leaders are learning to trust AI agents, but not with production

AI coding agents have moved quickly from novelty to daily tool inside Southeast Asian engineering teams. Across Singapore, Bangkok, Jakarta and Ho Chi Minh City, developers are no longer just asking AI to complete a line of code or explain an error message. They are using agents to plan tasks, refactor repositories, generate tests and […] The post Southeast Asian tech leaders are learning to trust AI agents, but not with production appeared first on e27.

Nuri rocket successfully deploy 15 satellites
Oct 7, 2026
Nuri rocket successfully deploy 15 satellites

The Nuri rocket successfully lifted off in its fifth launch and deployed 15 satellites into their target orbit, Wednesday. The rocket lifted off from the second launch pad at the Naro Space Center in Goheung, Jeonnam-Gwangju Special Metropolitan City, at 12:25 p.m. and completed its roughly 20-minute flight at around 12:45 p.m. The rocket separated its first stage about two minutes after liftoff, followed by the second stage about four and a half minutes into the flight. At around 12:40 p.m., it reached an altitude of 570 kilometers and completed the sequential deployment of five NEONSAT swarm microsatellites, its primary payload, and 10 CubeSats. The flight ended at around 12:45 p.m. after the third stage completed its autopilot sequence. "The Nuri rocket has been confirmed to have reached its target orbit in accordance with the planned flight sequence, and all five NEONSAT swarm microsatellites were separated in the planned order,” Korea AeroSpace Administration (KASA) Administrator Oh Tae-seog said. “Based on the satellite deployment process and flight status confirmed so far, the

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

About Us

Always dynamic, always updated, The Witness Daily ensures minute-by-minute update to the most pressing issues, curated specifically to cater to critical newsreaders of our time.

Copyright © 2015 - 2026 Redshift Daily. All Rights Reserved.